Tech Company Financing Transactions
Xilis Funding Round
Xilis closed a $19 million Series A venture capital round on 7/13/2022. Investors included Alexandria Venture Investments, Alix Ventures and Catalio Capital Management.
Transaction Overview
Company Name
Announced On
7/13/2022
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series A
Investors
Proceeds Purpose
The company will use the Series A funding to advance its proprietary MOS platform.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
801 Capitola Dr. 12
Durham, NC 27713
USA
Durham, NC 27713
USA
Phone
Undisclosed
Website
Email Address
Overview
Xilis is a Stanford PhD and a PhD from UNC Chapel Hill (both now Duke University professors focused on oncology and precision health) came together for this company out of their acute awareness that when someone is diagnosed with cancer, finding the right treatment frequently takes months and often comes with countless side effects.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Xiling Shen
Chief Financial Officer
Gary Yeung
Chief Medical Officer
David Hsu
Chief Operating Officer
Daniel Delubac
Chief Scientific Officer
Hans Clevers
VP - Bus. Development
Stan Skrzypczak
Browse more venture capital transactions:
Prev: 7/13/2022: Vascular Dynamics venture capital transaction
Next: 7/13/2022: Zinklar venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs